Sven-Eric Olsson

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations

Veterinary Medicine, Infectious Diseases, Oncology +17

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Luisa L. Villa, Kevin A. Ault, Anna R. Giuliano et al. · Vaccine · 2006 · 469 citations

Medicine, Immunology, Oncology +14

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

Sven-Eric Olsson, Susanne K. Kjær, Kristján Sigurðsson et al. · Human Vaccines · 2009 · 218 citations · Full text

Medicine, Immunology, Preventive Medicine +17

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

Elmar A. Joura, Susanne K. Kjær, Cosette M. Wheeler et al. · Vaccine · 2008 · 196 citations · Full text

Veterinary Medicine, Immunology, Preventive Medicine +16

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up

Sven-Eric Olsson, Jaime Alberto Restrepo, Julio C. Reina et al. · Papillomavirus Research · 2020 · 61 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +11